10x Genomics, Inc. company logo
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) Cash From Operations

Annual CFO

$6.66M$21.86M+143.85%

Summary

Current Value
As of today, TXG annual cash from operations is $6.66M, up +143.85% on
Historical Performance
TXG annual cash from operations is up +131.18% over the past 3 years, and down -80.75% over the past 5 years
All-Time High Comparison
TXG annual cash from operations is currently -80.75% below its historical high of $34.63M set on
3-Year Low Comparison
TXG annual cash from operations is +119.83% above its 3-year low of -$33.61M reached on an earlier date
Sector Comparison
TXG annual cash from operations is higher than 76.02% of companies in Healthcare sector

Cash From Operations Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

TXG Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Operations$6.66M+143.8%+131.2%-80.8%+162.3%
Quarterly Cash From Operations$43.21M+99.7%+551.8%+177.7%
TTM Cash From Operations$88.53M+126.0%+313.2%+209.3%
Price$19.99+28.7%-47.1%-87.4%
Annual Cash From Investing-$32.63M-124.4%+69.4%+23.7%-768.8%
Annual Cash From Financing$10.91M-20.2%-69.1%-97.4%-47.0%
Annual Free Cash Flow-$6.73M+89.6%+94.5%+17.3%+53.5%
Annual CAPEX$13.39M-73.0%-86.8%-68.7%+256.6%
Annual Net Income-$182.63M+28.4%-213.7%-484.4%-873.4%

Cash From Operations Highs

TXG Annual Cash From Operations Highs Comparison
PeriodHighDateCurrent
3Y$6.66Mat high
5Y$6.66Mat high
All$34.63M-80.8%

Cash From Operations Lows

TXG Annual Cash From Operations Lows Comparison
PeriodLowDateCurrent
3Y-$33.61MN/A+119.8%
5Y-$217.90MN/A+103.1%
All-$217.90M+103.1%

Cash From Operations History

YearValueChange
$6.66M+143.9%
-$15.20M+54.8%
-$33.61M-57.2%
-$21.37M+90.2%
YearValueChange
-$217.90M-729.3%
$34.63M+145.3%
-$76.41M-614.2%
-$10.70M-

FAQ

  • What is the current annual cash from operations of TXG?

    As of today, TXG annual cash from operations is $6.66M

  • What is 1-year change in TXG annual cash from operations?

    TXG annual cash from operations is up +143.85% year-over-year

  • What is 3-year change in TXG annual cash from operations?

    TXG annual cash from operations is up +131.18% over the past 3 years

  • How far is TXG annual cash from operations from its all-time high?

    TXG annual cash from operations is currently -80.75% below its historical high of $34.63M set on December 31, 2019

  • How does TXG annual cash from operations rank versus sector peers?

    TXG annual cash from operations is higher than 76.02% of companies in Healthcare sector

  • When is TXG next annual earnings release?

    The next annual earnings release for TXG is on

Cash From Operations Formula

CFO = + Non Cash Expenses + Changes In

Data Sources & References

  1. TXG Official Website www.10xgenomics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1770787/000162828025050332/0001628280-25-050332-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000177078725000013/0001770787-25-000013-index.htm
  4. TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
  5. TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg